This inventor holds 2 USPTO granted patents and 10 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Seasun Therapeutics. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2024
Title: Hye Joo Kim: Innovator in Skin-Penetrating Carriers
Introduction
Hye Joo Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of skin-permeating carriers for nucleic acids. With a total of 2 patents, his work focuses on enhancing the delivery of bioactive substances into cells.
Latest Patents
Hye Joo Kim's latest patents include innovative technologies that address the challenges of drug delivery. One of his notable inventions is a skin-permeating carrier containing a nucleic acid complex. This carrier has a novel structure that effectively introduces bioactive nucleic acids into cells. The composition is designed for diagnosing, preventing, or treating diseases, utilizing a skin-penetrating carrier that ensures both skin permeability and retention. Another significant patent involves a peptide nucleic acid complex that improves cell permeability, allowing for the regulation of target gene expression.
Career Highlights
Hye Joo Kim is currently associated with Seasun Therapeutics, where he continues to advance his research in biotechnology. His work has the potential to revolutionize treatments by enabling external applications that penetrate the skin effectively.
Collaborations
Hye Joo Kim collaborates with talented individuals in his field, including Ji-Yeon Yu and Hee Kyung Park. Their combined expertise contributes to the innovative projects at Seasun Therapeutics.
Conclusion
Hye Joo Kim's contributions to the field of biotechnology, particularly in skin-permeating carriers, highlight his role as a leading inventor. His patents reflect a commitment to improving drug delivery systems, which could have a lasting impact on medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile